Patent ID: 7902339

Claim:
An antibody, or antigen binding fragment thereof, wherein the antibody or antigen binding fragment thereof comprises the complementarity determining regions (CDRs) of monoclonal antibody DMF10.62.3 and wherein the antibody is selected from the group consisting of: (i) monoclonal antibody DMF10.62.3 produced by hybridoma cell line ATCC No. PTA-377, (ii) a chimeric version of monoclonal antibody DMF10.62.3 comprising the light and heavy chain variable regions of monoclonal antibody DMF10.62.3 and human light and heavy chain constant regions, wherein said chimeric version specifically binds to the antigen to which monoclonal antibody DMF10.62.3 binds, and (iii) a humanized version of monoclonal antibody DMF10.62.3 comprising the complementarity determining regions (CDRs) of monoclonal antibody DMF10.62.3, wherein said humanized version specifically binds to the antigen to which monoclonal antibody DMF10.62.3 binds.